We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Millions of PCR Reactions Occur in Single Tube

By LabMedica International staff writers
Posted on 30 May 2011
Improved polymerase chain reaction (PCR) technology enables millions of PCR reactions in a single tube.

Following fragmentation using specifically selected restriction endonucleases, and denaturing of the DNA sample, a selector probe library is added. More...
Each probe can hybridize to both ends of a targeted DNA restriction fragment; it guides the targeted fragments to form circular DNA molecules. Only circular DNA targets are amplified, ready for sequencing using any next-generation procedure, and results are highly reproducible.

The new HaloPlex Target Enrichment Kit is available exclusively in the UK from Cambio (Cambridge, United Kingdom). It represents a new concept in next-generation sequencing, reducing costs and saving up to 80 % in sample preparation time.

According to Dr. Naeem Ahmed, Cambio's technical support specialist, "This new Halo Genomics kit provides a ‘lab-in-a-tube' solution, which greatly simplifies PCR workflow, with no need for expensive instrumentation or automation. With next-generation nanoscale PCR, reactions are parallelized at the molecular level so that no separate time-consuming library preparation stage is required. For a project targeting 100 genes in 1,000 samples, HaloPlex Target Enrichment Kit reduces the total sample preparation time by as much as 80 percent. Genomic regions of interest are enriched at the same time as the introduction of sample barcoding and sequence motifs."

The HaloPlex PCR reagent kit for high performance targeted resequencing applications include studies of candidate genes involved in rare inherited diseases, pathway sequencing in matched tumor and normal samples, and clinical sequencing for BRCA gene assays.

Related Links:

Cambio





Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
New
HPV Test
Allplex HPV28 Detection
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Microbiology

view channel
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.